Cargando…
The malignancy of chordomas is enhanced via a circTLK1/miR-16-5p/Smad3 positive feedback axis
CircRNAs play crucial roles in various malignancies via an increasing number of reported regulatory mechanisms, including the classic sponging mechanism between circRNAs and micro RNAs (miRNAs). We performed bioinformatic analyses and identified circTLK1 as a regulator of malignant chordoma progress...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932141/ https://www.ncbi.nlm.nih.gov/pubmed/36792585 http://dx.doi.org/10.1038/s41420-023-01332-1 |
_version_ | 1784889385708158976 |
---|---|
author | Lou, Jingbing Zhang, Hongliang Huang, Qingshan Chen, Chenglong Wang, Wei Niu, Jianfang Xu, Jiuhui Ren, Tingting Huang, Yi Tang, Xiaodong Guo, Wei |
author_facet | Lou, Jingbing Zhang, Hongliang Huang, Qingshan Chen, Chenglong Wang, Wei Niu, Jianfang Xu, Jiuhui Ren, Tingting Huang, Yi Tang, Xiaodong Guo, Wei |
author_sort | Lou, Jingbing |
collection | PubMed |
description | CircRNAs play crucial roles in various malignancies via an increasing number of reported regulatory mechanisms, including the classic sponging mechanism between circRNAs and micro RNAs (miRNAs). We performed bioinformatic analyses and identified circTLK1 as a regulator of malignant chordoma progression. Moreover, we observed that circTLK1 showed high expression in chordoma cells and tissues, while circTLK1 interference suppressed chordoma cell proliferation and invasion. In addition, circTLK1 directly interacted with miR-16-5p, which has previously been shown to repress chordoma, and circTLK1 knockdown suppressed Smad3 expression. Chromatin immunoprecipitation sequencing further demonstrated that Smad3 acts as a positive regulator by interacting with TLK1, thereby mediating the circTLK1/miR-16-5p/Smad3 positive feedback axis. Taken together, our findings suggested that the disruption of the circTLK1/miR-16-5p/Smad3 positive feedback pathway, particularly via the Smad3 inhibitor SIS3, could be a promising therapeutic strategy. |
format | Online Article Text |
id | pubmed-9932141 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-99321412023-02-17 The malignancy of chordomas is enhanced via a circTLK1/miR-16-5p/Smad3 positive feedback axis Lou, Jingbing Zhang, Hongliang Huang, Qingshan Chen, Chenglong Wang, Wei Niu, Jianfang Xu, Jiuhui Ren, Tingting Huang, Yi Tang, Xiaodong Guo, Wei Cell Death Discov Article CircRNAs play crucial roles in various malignancies via an increasing number of reported regulatory mechanisms, including the classic sponging mechanism between circRNAs and micro RNAs (miRNAs). We performed bioinformatic analyses and identified circTLK1 as a regulator of malignant chordoma progression. Moreover, we observed that circTLK1 showed high expression in chordoma cells and tissues, while circTLK1 interference suppressed chordoma cell proliferation and invasion. In addition, circTLK1 directly interacted with miR-16-5p, which has previously been shown to repress chordoma, and circTLK1 knockdown suppressed Smad3 expression. Chromatin immunoprecipitation sequencing further demonstrated that Smad3 acts as a positive regulator by interacting with TLK1, thereby mediating the circTLK1/miR-16-5p/Smad3 positive feedback axis. Taken together, our findings suggested that the disruption of the circTLK1/miR-16-5p/Smad3 positive feedback pathway, particularly via the Smad3 inhibitor SIS3, could be a promising therapeutic strategy. Nature Publishing Group UK 2023-02-15 /pmc/articles/PMC9932141/ /pubmed/36792585 http://dx.doi.org/10.1038/s41420-023-01332-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Lou, Jingbing Zhang, Hongliang Huang, Qingshan Chen, Chenglong Wang, Wei Niu, Jianfang Xu, Jiuhui Ren, Tingting Huang, Yi Tang, Xiaodong Guo, Wei The malignancy of chordomas is enhanced via a circTLK1/miR-16-5p/Smad3 positive feedback axis |
title | The malignancy of chordomas is enhanced via a circTLK1/miR-16-5p/Smad3 positive feedback axis |
title_full | The malignancy of chordomas is enhanced via a circTLK1/miR-16-5p/Smad3 positive feedback axis |
title_fullStr | The malignancy of chordomas is enhanced via a circTLK1/miR-16-5p/Smad3 positive feedback axis |
title_full_unstemmed | The malignancy of chordomas is enhanced via a circTLK1/miR-16-5p/Smad3 positive feedback axis |
title_short | The malignancy of chordomas is enhanced via a circTLK1/miR-16-5p/Smad3 positive feedback axis |
title_sort | malignancy of chordomas is enhanced via a circtlk1/mir-16-5p/smad3 positive feedback axis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932141/ https://www.ncbi.nlm.nih.gov/pubmed/36792585 http://dx.doi.org/10.1038/s41420-023-01332-1 |
work_keys_str_mv | AT loujingbing themalignancyofchordomasisenhancedviaacirctlk1mir165psmad3positivefeedbackaxis AT zhanghongliang themalignancyofchordomasisenhancedviaacirctlk1mir165psmad3positivefeedbackaxis AT huangqingshan themalignancyofchordomasisenhancedviaacirctlk1mir165psmad3positivefeedbackaxis AT chenchenglong themalignancyofchordomasisenhancedviaacirctlk1mir165psmad3positivefeedbackaxis AT wangwei themalignancyofchordomasisenhancedviaacirctlk1mir165psmad3positivefeedbackaxis AT niujianfang themalignancyofchordomasisenhancedviaacirctlk1mir165psmad3positivefeedbackaxis AT xujiuhui themalignancyofchordomasisenhancedviaacirctlk1mir165psmad3positivefeedbackaxis AT rentingting themalignancyofchordomasisenhancedviaacirctlk1mir165psmad3positivefeedbackaxis AT huangyi themalignancyofchordomasisenhancedviaacirctlk1mir165psmad3positivefeedbackaxis AT tangxiaodong themalignancyofchordomasisenhancedviaacirctlk1mir165psmad3positivefeedbackaxis AT guowei themalignancyofchordomasisenhancedviaacirctlk1mir165psmad3positivefeedbackaxis AT loujingbing malignancyofchordomasisenhancedviaacirctlk1mir165psmad3positivefeedbackaxis AT zhanghongliang malignancyofchordomasisenhancedviaacirctlk1mir165psmad3positivefeedbackaxis AT huangqingshan malignancyofchordomasisenhancedviaacirctlk1mir165psmad3positivefeedbackaxis AT chenchenglong malignancyofchordomasisenhancedviaacirctlk1mir165psmad3positivefeedbackaxis AT wangwei malignancyofchordomasisenhancedviaacirctlk1mir165psmad3positivefeedbackaxis AT niujianfang malignancyofchordomasisenhancedviaacirctlk1mir165psmad3positivefeedbackaxis AT xujiuhui malignancyofchordomasisenhancedviaacirctlk1mir165psmad3positivefeedbackaxis AT rentingting malignancyofchordomasisenhancedviaacirctlk1mir165psmad3positivefeedbackaxis AT huangyi malignancyofchordomasisenhancedviaacirctlk1mir165psmad3positivefeedbackaxis AT tangxiaodong malignancyofchordomasisenhancedviaacirctlk1mir165psmad3positivefeedbackaxis AT guowei malignancyofchordomasisenhancedviaacirctlk1mir165psmad3positivefeedbackaxis |